484 related articles for article (PubMed ID: 29850779)
1. Apoptotic cell induction of miR-10b in macrophages contributes to advanced atherosclerosis progression in ApoE-/- mice.
Wang D; Wang W; Lin W; Yang W; Zhang P; Chen M; Ding D; Liu C; Zheng J; Ling W
Cardiovasc Res; 2018 Nov; 114(13):1794-1805. PubMed ID: 29850779
[TBL] [Abstract][Full Text] [Related]
2. Diosgenin inhibits atherosclerosis via suppressing the MiR-19b-induced downregulation of ATP-binding cassette transporter A1.
Lv YC; Yang J; Yao F; Xie W; Tang YY; Ouyang XP; He PP; Tan YL; Li L; Zhang M; Liu D; Cayabyab FS; Zheng XL; Tang CK
Atherosclerosis; 2015 May; 240(1):80-9. PubMed ID: 25765596
[TBL] [Abstract][Full Text] [Related]
3. Krüppel-like factor 14 deletion in myeloid cells accelerates atherosclerotic lesion development.
Wang H; Guo Y; Lu H; Luo Y; Hu W; Liang W; Garcia-Barrio MT; Chang L; Schwendeman A; Zhang J; Chen YE
Cardiovasc Res; 2022 Jan; 118(2):475-488. PubMed ID: 33538785
[TBL] [Abstract][Full Text] [Related]
4. CTRP12 ameliorates atherosclerosis by promoting cholesterol efflux and inhibiting inflammatory response via the miR-155-5p/LXRα pathway.
Wang G; Chen JJ; Deng WY; Ren K; Yin SH; Yu XH
Cell Death Dis; 2021 Mar; 12(3):254. PubMed ID: 33692340
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis.
Meiler S; Baumer Y; Toulmin E; Seng K; Boisvert WA
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):323-31. PubMed ID: 25524771
[TBL] [Abstract][Full Text] [Related]
6. Melanocortin 1 Receptor Deficiency Promotes Atherosclerosis in Apolipoprotein E
Rinne P; Kadiri JJ; Velasco-Delgado M; Nuutinen S; Viitala M; Hollmén M; Rami M; Savontaus E; Steffens S
Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):313-323. PubMed ID: 29284608
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-19b promotes macrophage cholesterol accumulation and aortic atherosclerosis by targeting ATP-binding cassette transporter A1.
Lv YC; Tang YY; Peng J; Zhao GJ; Yang J; Yao F; Ouyang XP; He PP; Xie W; Tan YL; Zhang M; Liu D; Tang DP; Cayabyab FS; Zheng XL; Zhang DW; Tian GP; Tang CK
Atherosclerosis; 2014 Sep; 236(1):215-26. PubMed ID: 25084135
[TBL] [Abstract][Full Text] [Related]
8. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice.
Gui Y; Yao S; Yan H; Hu L; Yu C; Gao F; Xi C; Li H; Ye Y; Wang Y
Cardiovasc Res; 2016 Oct; 112(1):502-14. PubMed ID: 27460841
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-205-5p Promotes Unstable Atherosclerotic Plaque Formation In Vivo.
Meng X; Yin J; Yu X; Guo Y
Cardiovasc Drugs Ther; 2020 Feb; 34(1):25-39. PubMed ID: 32034643
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-23a-5p promotes atherosclerotic plaque progression and vulnerability by repressing ATP-binding cassette transporter A1/G1 in macrophages.
Yang S; Ye ZM; Chen S; Luo XY; Chen SL; Mao L; Li Y; Jin H; Yu C; Xiang FX; Xie MX; Chang J; Xia YP; Hu B
J Mol Cell Cardiol; 2018 Oct; 123():139-149. PubMed ID: 30227118
[TBL] [Abstract][Full Text] [Related]
11. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
[TBL] [Abstract][Full Text] [Related]
12. Haloperidol inhibits the development of atherosclerotic lesions in LDL receptor knockout mice.
van der Sluis RJ; Nahon JE; Reuwer AQ; Van Eck M; Hoekstra M
Br J Pharmacol; 2015 May; 172(9):2397-405. PubMed ID: 25572138
[TBL] [Abstract][Full Text] [Related]
13. TUG1 knockdown ameliorates atherosclerosis via up-regulating the expression of miR-133a target gene FGF1.
Zhang L; Cheng H; Yue Y; Li S; Zhang D; He R
Cardiovasc Pathol; 2018; 33():6-15. PubMed ID: 29268138
[TBL] [Abstract][Full Text] [Related]
14. Sortilin promotes macrophage cholesterol accumulation and aortic atherosclerosis through lysosomal degradation of ATP-binding cassette transporter A1 protein.
Lv Y; Yang J; Gao A; Sun S; Zheng X; Chen X; Wan W; Tang C; Xie W; Li S; Guo D; Peng T; Zhao G; Zhong L
Acta Biochim Biophys Sin (Shanghai); 2019 May; 51(5):471-483. PubMed ID: 30950489
[TBL] [Abstract][Full Text] [Related]
15. Heat shock protein 70 accelerates atherosclerosis by downregulating the expression of ABCA1 and ABCG1 through the JNK/Elk-1 pathway.
Zhao ZW; Zhang M; Chen LY; Gong D; Xia XD; Yu XH; Wang SQ; Ou X; Dai XY; Zheng XL; Zhang DW; Tang CK
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Aug; 1863(8):806-822. PubMed ID: 29678642
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Csf1r and Bcl6 in macrophages mediates the stage-specific effects of microRNA-155 on atherosclerosis.
Wei Y; Zhu M; Corbalán-Campos J; Heyll K; Weber C; Schober A
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):796-803. PubMed ID: 25810298
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-20a/b regulates cholesterol efflux through post-transcriptional repression of ATP-binding cassette transporter A1.
Liang B; Wang X; Song X; Bai R; Yang H; Yang Z; Xiao C; Bian Y
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):929-938. PubMed ID: 28602962
[TBL] [Abstract][Full Text] [Related]
18. Targeted invalidation of SR-B1 in macrophages reduces macrophage apoptosis and accelerates atherosclerosis.
Galle-Treger L; Moreau M; Ballaire R; Poupel L; Huby T; Sasso E; Troise F; Poti F; Lesnik P; Le Goff W; Gautier EL; Huby T
Cardiovasc Res; 2020 Mar; 116(3):554-565. PubMed ID: 31119270
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function.
Mehta NU; Grijalva V; Hama S; Wagner A; Navab M; Fogelman AM; Reddy ST
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1152-63. PubMed ID: 27079878
[TBL] [Abstract][Full Text] [Related]
20. LongShengZhi Capsule Reduces Established Atherosclerotic Lesions in apoE-Deficient Mice by Ameliorating Hepatic Lipid Metabolism and Inhibiting Inflammation.
Ma J; Zhao D; Wang X; Ma C; Feng K; Zhang S; Chen Y; Zhu Y; Gao X; Zhao B; Wang Y; Qian K; Li X; Duan Y; Han J; Yang X
J Cardiovasc Pharmacol; 2019 Feb; 73(2):105-117. PubMed ID: 30540683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
